Latest Racing News

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

EPX Limited has submitted a proposal to acquire WattWatchers Pty Limited through a Deed of Company Arrangement, pending creditor approval. The move aims to integrate WattWatchers’ real-time energy monitoring solutions with EPX’s advanced building performance platform.

Locksley Resources has raised A$17 million in an oversubscribed placement led by U.S. institutional investors, accelerating its strategy to develop a domestic supply chain for antimony and rare earths in California.

BetMakers Technology Group has signed a definitive agreement to acquire Las Vegas Dissemination Company, gaining direct access to major Nevada casino operators and projecting $4.5 million revenue in the first year.

Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

Predictive Discovery has received a compelling unsolicited acquisition proposal from Perseus Mining, valuing the company at A$2.1 billion and triggering a competitive matching period with Robex Resources.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Battery Age Minerals has appointed DGWA as its European strategic advisor to advance the Bleiberg Zinc Germanium Project within the EU’s Critical Raw Materials Act framework, initiating high-level engagements across key EU capitals.

Evion Group has landed a significant A$1.5 million order to supply expandable graphite to a major US graphite supply chain company, reinforcing its position as a trusted non-Chinese supplier amid growing demand.

Race Oncology has received a $2.8 million Australian R&D tax refund for FY2025, with further overseas R&D rebates expected, bolstering its clinical development of innovative cancer therapies.